Average Co-Inventor Count = 7.78
ph-index = 18
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Healthcare LLC (23 from 780 patents)
2. Bayer Pharmaceuticals Corporation (18 from 70 patents)
3. Bayer Aktiengesellschaft (9 from 12,160 patents)
4. Bayer Intellectual Property Gmbh (3 from 721 patents)
5. Smithkline Beecham Corporation (1 from 2,198 patents)
6. Bayer Schering Pharma Ag (1 from 192 patents)
7. Bayer Pharma Aktiengesellschaft (378 patents)
55 patents:
1. 10653684 - Aryl ureas with angiogenisis inhibiting activity
2. 9181188 - Aryl ureas as kinase inhibitors
3. 8841330 - Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
4. 8796250 - Diaryl ureas for diseases mediated by PDGFR
5. 8637553 - Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
6. 8618141 - Aryl ureas with angiogenesis inhibiting activity
7. 8580798 - Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders
8. 8431695 - Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
9. 8242147 - Aryl ureas with angiogenisis inhibiting activity
10. 8207172 - Pyrimidinothienoindazoles useful for the treatment of hyperproliferative disorders
11. 8207166 - Substituted pyrazolyl urea derivatives useful in the treatment of cancer
12. 8124630 - ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
13. 8110587 - Aryl ureas as kinase inhibitors
14. 8076488 - Bicyclic urea derivatives useful in the treatment of cancer and other disorders
15. 8071616 - Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors